Between 1948 and 1959 Georges worked at  CNRS before  joining CERN in Geneva. In 1984 he was given the title Joliot-Curie Professor at the Ecole Supérieure de Physique et de Chimie of Paris.

In 1992 Georges Charpak received the Nobel Prize in Physics for this work in the development of particle detectors, and in particular the multiwire proportional chamber, an elegant and economical solution to a complex problem.

His pioneering work came in 1968, when he realized the importance of connecting the detector directly to a computer, enabling researchers to record the trajectories of particles with greater accuracy and in much larger numbers compared with previous techniques.

He has since created many different types of detector that have played a fundamental role in the subnuclear physics of the past twenty years and in the development of new imaging techniques using ionizing and beta radiation recently adopted in medicine and biology.

Georges Charpak has received many international awards and honors, including the Paul Ricard Prize  from the Societé Française de Physique in 1980, the Prize from the Commissariat à l'Energie Atomique de l'Académie des Sciences in 1984 and the High Energy and Particle Physics Prize from the European Physical Society in 1989.

He is a member of the Académie Française des Sciences and an honary member of the National Academy of Sciences in the United States, the Russian Academy of Science and the Austrian Academy of Science.

Jacques joined ATL Ultrasound in 1981 as principal scientist in the cardiology departement. Between 1993 and 2000 he became CTO and Senior Vice President for Product Generation.

Continuing his career with ATL Ultrasound, between March 1989 and June 1993, Dr. Souquet served as Director of Strategic Marketing and Product Planning and Vice President for Product Generation.

Dr. Souquet received a Higher Engineering Degree from Ecole Superieure d'Electricite of Paris, France, a Ph.D. from the Orsay University of France in the field of optical memory, and a second Ph.D. from Stanford University in the field of new acoustic imaging techniques for medical ultrasound applications and nondestructive testing.

Dr. Souquet is a member of the board of Directors of SonoSite, Inc., an ultrasound imaging company leader in the field of hand-carried ultrasound.

He is also on the board of Directors of Median Technologies, a French company in medical computer aided detection systems.

He is the inventor of the multiplane transesophageal echo probe, which is now used in 30% of all ultrasound echocardiography examinations.

Dr. Souquet holds 10 patents in the field of ultrasound imaging. He is the author of more than 50 technical papers and is  a keynote speaker at major technical and clinical meetings worldwide.

Mathias Fink is a Professor of Physics at the Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI) and at  the Paris University (Denis Diderot), France.

He was nominated to the French Academy of Engineering in 2002 and  to the French Academy of Science in 2003.

Mathias's principle area of research is in the propagation of waves in complex media which has led to the  development of a number of  associated instruments.  The application of these instruments covers many scientific sectors including: medical imaging and therapy, underwater acoustics, seismology, non-destructive testing, telecommunications, tactile screens and instrumentation.

Dr Fink has had a long history of collaboration with industry. He works with companies in a wide variety of sectors including :medical, aeronautics, underwater acoustics, nuclear, metallurgy and instrumentation.

He pioneered many innovative approaches as “time-reversal mirrors” or “transient elastography”.

He holds more than 30 patents and he has published more than 300 papers.

Claude was senior scientist at Philips Research France between 1996 and 2002. His research interests were ultrasound vascular applications and Elastography for the breast.

Cluade headed a multinational project on breast ultrasound from 1999 to 2002 and launched several clinical investigations into new imaging protocols at various sites in France and the United States.

Claude Cohen-Bacrie received an engineering degree in electrical engineering and computer science from the Ecole Nationale Supérieure de l'Electronique et de ses Applications in 1992. He graduated  with a Masters Degree in Signal and image processing from the University of Orsay in 1992.

He then specialised in medical imaging and biomedical engineering at  the Ecole Polytechnique de Montreal, Canada, and worked on Electrical Impedance Tomography with an  specialisation in lung emphysema detection.

He graduated with a second Masters degree in 1994 and joined  Electricite de France as a research assistant to develop innovative algorithms on Eddy current tomography for non destructive testing.

Claude Cohen-Bacrie holds 10 patents in the field of medical imaging and makes regular contributions to key scientific conferences in the field of ultrasound.

Dr Grenier holds many prestigious appointments including:Resident in Radiology in Bordeaux (October 1980 - May 1986), Fellow in Radiology (Pr Broussin, Bordeaux) (May 1986 - May 1990), DEA de Biologie-Santé, Option Imagerie Fonctionnelle, Université de Bordeaux II (June 1988)

Dr Grenier is a member of the following Scientific Societies: Société Française de Radiologie (SFR), European Congress of Radiology (ECR), International Society of Magnetic Resonance (ISMR), Radiological Society of North America (RSNA).

Dr Grenier has served on numerous editorial and scientific boards including Revue d'Imagerie Médicale, Journal de Radiologie (from 1996), Feuillets de Radiologie (from 1996) and European Radiology Scientific Board (from 1995).

Dr Grenier’s other specialities include Vascular Radiology, Uroradiology and Ultrasound. His research themes are Functional MR imaging of the kidney, Cellular MR imaging of the kidney and Interventional MRI with RF and focused ultrasound.

Dr Grenier has published numerous scientific papers and has been the lead clinical investigator for multicenter and pilot studies in the field of Radiology.

In 1998 Gail was awarded a DSc in clinical medicine by the University of Oxford for her work on the safety of ultrasonic imaging and her research into the therapeutic applications of ultrasound.

Gail ter Haar is currently head of therapeutic ultrasound at the Institute of Cancer Research, Sutton, Surrey, UK. Her interests are mainly in the development of therapeutic applications of ultrasound for use in the treatment of cancer (especially high intensity focused ultrasound, HIFU), investigation of the potential of ultrasound for creating vascular occlusion for therapeutic benefit and the safety of diagnostic ultrasound techniques.

She has published 124 papers and written extensively in various medical publications.

Gail has recently been appointed visiting Professor of Therapeutic Ultrasound in the Nuffield Department of surgery at Oxford University.

She is founder and President of the International Society for Therapy Ultrasound (ISTU), chair of the European Committee for Ultrasound Radiation Safety, and sits on the Safety Committee of the British Medical Ultrasound Society and is a member of the Radiation Protection Committee of the British Institute of Radiology.

She is an honorary fellow of the American Institute for Ultrasound in Medicine and a fellow of both the Acoustic Society of America and the Institute of Engineering and Physics in Medicine.

Gail is the Associate Editor of Therapy Ultrasound for the journal Ultrasound in Medicine and Biology and is an associate editor of Ultrasonics.

Dr. Cosgrove's three main themes of academic interest are firstly, advancing the clinical role of "radiological"  (non-obstetric) ultrasound; secondly, furthering the understanding of the basic mechanisms of  the ultrasound image-forming process and  Doppler; and thirdly, applications of microbubble echo-enhancing (contrast) agents for ultrasound.

Dr. Cosgrove is the author of key seminal papers in the field of ultrasound and is regularly invited as a keynote speaker at major conferences around the world.

David Cosgrove received a BA from Oxford University in 1961;an BM BCh from St. Georges Hospital Medical School, London and Oxford University in 1963; an MRCP from London university in 1967; and an MSc in Nuclear Medicine from the University of London in 1975 (a comparison of liver scintiscans and ultrasonography in clinical diagnosis).

Dr Greenleaf is currently Professor of Biophysics and Associate Professor of Medicine at the Mayo Medical School,  Consultant in the Department of Physiology, Biophysics, and Cardiovascular Disease and Medicine at the Mayo Foundation.

Doctor Greenleaf was President of the Ultrasonics Ferroelectrics and Frequency Control Society of the IEEE between 1992 and 1993.

Doctor Greenleaf holds 13 patents and received the 1986 J. Holmes Pioneer Award and the 1998 William J. Fry Memorial Lecture Award from the American Institute of Ultrasound in Medicine. He is a Fellow of IEEE, the American Institute of Ultrasound in Medicine, and the American Institute for Medical and Biological Engineering.

Doctor Greenleaf was the Distinguished Lecturer for IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society and received the Rayleigh award in 2004.

His special field of interest is in ultrasonic biomedical science,  he has published more than 327 articles and edited or written five books.

Dr Bamber has been Team Leader of the "Ultrasound and Optics Team" at the Joint Department of Physics, Institute of Cancer Research and Royal Marsden Hospital since 1986 with responsibility for managing a research team and supervising graduate students in applying ultrasonic  methods in cancer medicine.

Dr Bamber's special fields of interest include: basic acoustic measurements on tissue and correlation with histopathology, ultrasound image speckle and texture, visual perception (psychophysics) of ultrasound images and movies, ultrasonic methods in breast cancer, assessment of tumour response, estimation of tumour and organ volume, tumour blood flow, three-dimensional ultrasound imaging, ultrasound tissue motion tracking, tissue elasticity imaging, temperature imaging, high frequency ultrasonic imaging/tissue characterization, ultrasound and optical methods in skin cancer, microbubbles as contrast agents in ultrasound and MRI, ultrasound planning guidance and monitoring of cancer treatment using high intensity focused ultrasound and conformal radiotherapy, ultrasound in radiation dosimetry, microbubbles as gene therapy vectors, nanoparticles for molecular imaging.

Dr Bamber's articles have featured in various specialist publications. He has written 2 theses , 66 scientific publications , he holds 4 patents.

He is  a regular key note speaker at international and prestigious conferences.

He subsequently held  faculty positions in Radiology at Yale University and Thomas Jefferson University in Philadelphia  then moving to Toronto in 1991.

He worked as part of a team which first established detection of tumour blood flow with Doppler. He subsequently worked on Doppler methods for flow detection and haemodynamic measurements in the abdomen and pelvis.

In 1988 he began research with microbubbles as ultrasound contrast agents, focusing on the development of nonlinear methods such as harmonic, pulse inversion and amplitude modulation imaging as well as their clinical applications in perfusion imaging of the heart, abdomen and tumours.

He has received various academic prizes in his field including:

-The WFUMB Pioneer prize in 1988 ( World Frderation for Ultrasound in medicine and Biology)

- The 2002 Ian Donald Gold medal for Technical acheivements

- The 2002 Innovation ans excellence Trophy from the Canadian Society of Radiology.

- 2008 IEEE UFFC Distinguished Lecturer.

He is an honory member of the Australasian Society for Ultrasound in Medicine.